Abstract
Ketamine hydrochloride, a Schedule III drug under the Controlled Substances Act, is a dissociative anesthetic that has a combination of stimulant, depressant, hallucinogenic, and analgesic properties. This procedure utilizes solid phase extraction of blood, tissue, or urine samples to isolate ketamine (special K) and its metabolite norketamine. The extract is then assayed using selected ion monitoring gas chromatography/mass spectrometry for absolute structural confirmation of the compound and the compounds quantified by comparing responses of the unknown samples to the responses of standards.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Baselt, R. C. (2000) Disposition of Toxic Drugs and Chemicals in Man, 5th ed. Chem. Tox. Inst., pp. 456–458.
Moffatt, A. C., Osselton, M. D. and Widdop, B. (2004) Clarke’s Analysis of Drugs and Poisons, 3rd ed. Pharm Press, pp. 1152–1153.
Drug-Facilitated Sexual Assault Resource Guide. 2003-R0502-001. NDIC and George Mason University, pp. 9–11, May 2003.
Applications Manual (1991) CLEAN SCREEN Extraction Column. Worldwide Monitoring Corp. Horsham, PA.
Trace Application Manual; SPEware Corporation; San Pedro, CA (2004).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2010 Humana Press, a part of Springer Science+Business Media, LLC
About this protocol
Cite this protocol
Rohrig, T.P., Gamble, M., Cox, K. (2010). Identification and Quantitation of Ketamine in Biological Matrices Using Gas Chromatography-Mass Spectrometry (GC-MS). In: Garg, U., Hammett-Stabler, C. (eds) Clinical Applications of Mass Spectrometry. Methods in Molecular Biology, vol 603. Humana Press. https://doi.org/10.1007/978-1-60761-459-3_30
Download citation
DOI: https://doi.org/10.1007/978-1-60761-459-3_30
Published:
Publisher Name: Humana Press
Print ISBN: 978-1-60761-458-6
Online ISBN: 978-1-60761-459-3
eBook Packages: Springer Protocols